Save your place

Sign in to WhoBought

Please try again later.

Amgen Inc. (AMGN) institutional ownership

Latest close $364.17 Jul 20, 2026
Market cap$190.6B 52-week range SectorHealthcare
Funds holding · Q1 2026
2,778
reported AMGN position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $2.3B
1,411 buyers · 1,367 sellers

Amgen Inc. (AMGN) price and institutional activity

Dates

Q1 2026

$10.2B bought by 1411 investors
Capital World Investors$2.2BJPMorgan Chase & Co$1.8B +1,409 more
$12.5B sold by 1367 investors
Capital International Investors-$3.9BNorges-$2.4B +1,365 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Amgen Inc. (AMGN) institutional activity · 2,778

Investor Type Est. change Change Δ Own Date
Capital International Investors · Reduced −$3.9B
Change −11.1M Date Q1 2026
Capital International Investors Reduced· Q1 2026 −$3.9B −11.1M Q1 2026
Norges · Exited −$2.4B
Change −6.6M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$2.4B −6.6M −100.0% Q1 2026
Capital World Investors · Added +$2.2B
Change +6.2M Date Q1 2026
Capital World Investors Added· Q1 2026 +$2.2B +6.2M Q1 2026
JPMorgan Chase & Co · Added +$1.8B
Change +5.0M Date Q1 2026
JPMorgan Chase & Co Added· Q1 2026 +$1.8B +5.0M Q1 2026
Capital Research Global Investors · Added +$822M
Change +2.3M Δ Own +49.6% Date Q1 2026
Capital Research Global Investors Added· Q1 2026 +$822M +2.3M +49.6% Q1 2026
Pacer Advisors, Inc. · Exited −$448M
Change −1.3M Δ Own −100.0% Date Q1 2026
Pacer Advisors, Inc. Exited· Q1 2026 −$448M −1.3M −100.0% Q1 2026
Janus Henderson Group PLC · Reduced −$433M
Change −1.2M Date Q1 2026
Janus Henderson Group PLC Reduced· Q1 2026 −$433M −1.2M Q1 2026
Geode · Added +$402M
Change +1.1M Date Q1 2026
Geode Added· Q1 2026 +$402M +1.1M Q1 2026
Schwab · Added +$343M
Change +962K Date Q1 2026
Schwab Added· Q1 2026 +$343M +962K Q1 2026
UBS Group AG · Reduced −$341M
Change −956K Date Q1 2026
UBS Group AG Reduced· Q1 2026 −$341M −956K Q1 2026
T. Rowe Price Associates · Added +$293M
Change +823K Date Q1 2026
T. Rowe Price Associates Added· Q1 2026 +$293M +823K Q1 2026
Two Sigma Advisers, LP · Exited −$262M
Change −736K Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −$262M −736K −100.0% Q1 2026
Fisher Asset Management, LLC Added· Q1 2026 +$240M +674K +74.6% Q1 2026
Federated Hermes, Inc. · Reduced −$236M
Change −663K Date Q1 2026
Federated Hermes, Inc. Reduced· Q1 2026 −$236M −663K Q1 2026
Two Sigma Investments, LP · Reduced −$224M
Change −629K Δ Own −89.8% Date Q1 2026
Two Sigma Investments, LP Reduced· Q1 2026 −$224M −629K −89.8% Q1 2026
Data through Q1 2026 · filed Jun 11, 2026
15 of 2778

Famous investor activity in Amgen Inc. (AMGN)

Amgen Inc. (AMGN) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Miles Amy E. · Director Grant (A) 665
Owned 6K Trade date May 19, 2026 Filed date May 21, 2026
Miles Amy E. Director Grant (A) 665 6K May 19, 2026 May 21, 2026
Kullman Ellen Jamison · Director Grant (A) 665
Owned 15K Trade date May 19, 2026 Filed date May 21, 2026
Kullman Ellen Jamison Director Grant (A) 665 15K May 19, 2026 May 21, 2026
Klotman Mary E. · Director Grant (A) 665
Owned 2K Trade date May 19, 2026 Filed date May 21, 2026
Klotman Mary E. Director Grant (A) 665 2K May 19, 2026 May 21, 2026
Jacks Tyler · Director Grant (A) 665
Owned 18K Trade date May 19, 2026 Filed date May 21, 2026
Jacks Tyler Director Grant (A) 665 18K May 19, 2026 May 21, 2026
Ishrak Omar · Director Grant (A) 665
Owned 7K Trade date May 19, 2026 Filed date May 21, 2026
Ishrak Omar Director Grant (A) 665 7K May 19, 2026 May 21, 2026
Holley Charles M. · Director Grant (A) 665
Owned 13K Trade date May 19, 2026 Filed date May 21, 2026
Holley Charles M. Director Grant (A) 665 13K May 19, 2026 May 21, 2026
Garland Greg C. · Director Grant (A) 665
Owned 14K Trade date May 19, 2026 Filed date May 21, 2026
Garland Greg C. Director Grant (A) 665 14K May 19, 2026 May 21, 2026
Eckert Robert · Director Grant (A) 665
Owned 26K Trade date May 19, 2026 Filed date May 21, 2026
Eckert Robert Director Grant (A) 665 26K May 19, 2026 May 21, 2026
Druker Brian · Director Grant (A) 665
Owned 8K Trade date May 19, 2026 Filed date May 21, 2026
Druker Brian Director Grant (A) 665 8K May 19, 2026 May 21, 2026
Drake Michael V · Director Grant (A) 665
Owned 6K Trade date May 19, 2026 Filed date May 21, 2026
Drake Michael V Director Grant (A) 665 6K May 19, 2026 May 21, 2026
Austin Wanda M. · Director Grant (A) 665
Owned 8K Trade date May 19, 2026 Filed date May 21, 2026
Austin Wanda M. Director Grant (A) 665 8K May 19, 2026 May 21, 2026
Busch Matthew C. · Officer Tax withholding or exercise payment (F) -$14K
Price $331.11 Qty -41 Owned 4K Trade date May 7, 2026 Filed date May 11, 2026
Busch Matthew C. Officer Tax withholding or exercise payment (F) $331.11 -41 -$14K 4K May 7, 2026 May 11, 2026
Santos Esteban · Officer Tax withholding or exercise payment (F) -$173K
Price $331.11 Qty -522 Owned 83K Trade date May 7, 2026 Filed date May 11, 2026
Santos Esteban Officer Tax withholding or exercise payment (F) $331.11 -522 -$173K 83K May 7, 2026 May 11, 2026
Reese David M. · Officer Tax withholding or exercise payment (F) -$184K
Price $331.11 Qty -556 Owned 42K Trade date May 7, 2026 Filed date May 11, 2026
Reese David M. Officer Tax withholding or exercise payment (F) $331.11 -556 -$184K 42K May 7, 2026 May 11, 2026
Miller Derek · Officer Tax withholding or exercise payment (F) -$50K
Price $331.11 Qty -151 Owned 12K Trade date May 7, 2026 Filed date May 11, 2026
Miller Derek Officer Tax withholding or exercise payment (F) $331.11 -151 -$50K 12K May 7, 2026 May 11, 2026
15 of 99
15 of 99 Sign in to continue to older insider transactions.

Amgen Inc. (AMGN) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Vanguard Group Inc 49.0M
% of shares outstanding 9.2% Filing date Feb 13, 2024
Vanguard Group Inc 49.0M 9.2% Feb 13, 2024
BlackRock Inc. 47.8M
% of shares outstanding 8.9% Filing date Jan 25, 2024
BlackRock Inc. 47.8M 8.9% Jan 25, 2024
Vanguard Capital Management LLC 40.5M
% of shares outstanding 7.5% Filing date Apr 29, 2026
Vanguard Capital Management LLC 40.5M 7.5% Apr 29, 2026
State Street Corp
% of shares outstanding 5.5% Filing date Jan 30, 2024
State Street Corp 5.5% Jan 30, 2024
Capital World Investors 29.6M
% of shares outstanding 5.5% Filing date May 14, 2026
Capital World Investors 29.6M 5.5% May 14, 2026
Capital Research Global Investors 22.2M
% of shares outstanding 3.9% Filing date Feb 11, 2022
Capital Research Global Investors 22.2M 3.9% Feb 11, 2022
6 of 6

Amgen Inc. (AMGN) ownership FAQ

Who owns AMGN?

2,778 reporting institutions disclosed AMGN position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.